DIVISLAB had a stellar week, delivering a 7.46% return, significantly outperforming its peers. The stock's volatility was relatively high at 28.33%, but its Sharpe Ratio of 1.02 indicates that the return was achieved with a reasonable level of risk. Compared to its peers, DIVISLAB's performance was exceptional, with a higher return and lower volatility than DRREDDY and SUNPHARMA, and a higher Sharpe Ratio than CIPLA. Overall, the stock's performance was impressive, but investors should be aware of the moderate level of risk involved.

[Volatility: 28.33%]